ASXL1 and myelodysplastic syndrome: We previously reported that forced expression of a C-terminally truncated ASXL1 mutant in hematopoietic progenitor cells induced MDS-like diseases, and SETBP1 mutations drove leukaemic transformation in ASXL1-mutated MDS in mouse models18,19.